Bernhard zur Strassen succeeds Alexander Kohnen
Bernhard zur Strassen is set to be appointed as new Managing Director and CEO of time:matters GmbH. He will take over his new position as of 1 November 2023 and will succeed Alexander Kohnen, who left the company at his own accord in April 2023. Zur Strassen has extensive experience in international management for logistics service providers and shippers. Most recently, he held the position of Chief Revenue Officer at Shipsta S.à.r.l., a software company.
“We are delighted to have Bernhard zur Strassen on board as the new CEO of time:matters GmbH. He has an extensive and long-standing expertise in the field of logistics, making him optimally qualified to further establish time:matters as a company for time-critical emergency and highly flexible transport solutions,” says Frank Bauer, Chief Financial Officer and Labour Director at Lufthansa Cargo.
Bernhard zur Strassen began his logistics career at Lufthansa Cargo, where he authored his thesis for his business studies. He then held several international positions at Kühne + Nagel, a logistics service provider, in Switzerland, England, and Luxembourg. Zur Strassen subsequently oversaw the global transportation network and later managed the logistics and supply chain for a worldwide automotive industry supplier. At time:matters, he will drive international growth with customers, digitalisation and sustainability.
“I am very pleased to have Bernhard zur Strassen as an experienced industry expert at my side and to be able to continue the successful development of time:matters,” emphasizes Lars Krosch, Chief Operating Officer of time:matters.
Since its founding in the year 2002, the logistics company, which was fully acquired by Lufthansa Cargo in August 2016, has established itself as a global provider of time-critical emergency transport and supply chain solutions. Based on the respective transport requirements, time:matters offers fast, efficient, customer-centric and reliable transport solutions worldwide. Focus industries include medical technology, cell and gene therapy, aviation and aerospace, high-tech and semiconductors, automotive as well as industrial machinery and equipment. The company relies on state-of-the-art technology and an extensive network.
